FFA
AZN icon

Frazier Financial Advisors’s AstraZeneca AZN Stock Holding History

Frazier Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-466
Closed -$85.6K – 845
2025
Q4 		$85.6K Buy
466
+20
+4% +$3.51K 0.05% 119
2025
Q3 		$68.4K Hold
446
– – 0.04% 133
2025
Q2 		$62.3K Buy
446
+65
+17% +$9.11K 0.04% 130
2025
Q1 		$56K Hold
381
– – 0.04% 129
2024
Q4 		$50K Sell
381
-87
-19% -$12.2K 0.04% 135
2024
Q3 		$72.8K Sell
468
-150
-24% -$24.2K 0.06% 112
2024
Q2 		$96.4K Buy
618
+168
+37% +$25.3K 0.08% 98
2024
Q1 		$61K Buy
450
+10
+2% +$1.32K 0.05% 133
2023
Q4 		$59.3K Buy
+440
New +$57.2K 0.05% 123

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Frazier Financial Advisors's AZN Position: Q1 2026 in Review

Frazier Financial Advisors sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 466 shares — an estimated $85.6K sold.

Frazier Financial Advisors first reported a position in AZN in Q4 2023 and held it in 9 quarters. The position peaked at $96.4K in Q2 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Frazier Financial Advisors reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Frazier Financial Advisors sold 466 AstraZeneca shares in Q1 2026, an estimated $85.6K.
  • Frazier Financial Advisors first reported a position in AstraZeneca in Q4 2023 and held it in 9 quarters.
  • Frazier Financial Advisors's AstraZeneca position peaked at $96.4K in Q2 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.